Modulating the Baseline Impedance: An Adjunctive Technique for Maximizing Radiofrequency Lesion Dimensions in Deep and Intramural Ventricular Substrate: An Adjunctive Technique for Maximizing Radiofrequency Lesion Dimensions in Deep and Intramural Ventricular Substrate.


Journal

Circulation. Arrhythmia and electrophysiology
ISSN: 1941-3084
Titre abrégé: Circ Arrhythm Electrophysiol
Pays: United States
ID NLM: 101474365

Informations de publication

Date de publication:
06 2019
Historique:
entrez: 23 5 2019
pubmed: 23 5 2019
medline: 25 2 2020
Statut: ppublish

Résumé

Background Radiofrequency ablation of intramural ventricular substrate is often limited by insufficient tissue penetration despite high energy settings. As lesion dimensions have a direct and negative relationship to impedance, reducing the baseline impedance may increase the ablation effect on deep ventricular tissue. Methods This study included 16 patients with ventricular tachycardia or frequent ventricular premature complexes refractory to ablation with irrigated catheters. After a failed response to radiofrequency ablation, impedance was modulated by adding or repositioning return patches in an attempt to decrease the circuit impedance. Ablation was repeated at a similar location and power settings, and the effect on arrhythmia suppression and adverse effects were evaluated. Results Six patients with idiopathic ventricular premature complexes originating from the left ventricular summit (n=4) or papillary muscles (n=2), 6 patients with noninfarct related ventricular tachycardia and 4 patients with infarct-related ventricular tachycardia had unsuccessful response to radiofrequency ablation at critical sites (number of applications: 10.4±3.1, power: 42.3±2.9 W, duration: 55.3±25.5 seconds, impedance reduction: 14.6±3.5 Ω, low-ionic solution was used in 81.25%). Modulating the return patches resulted in reduced baseline impedance (111.7±8.2 versus 134.7±6.6 Ω, P<0.0001), increased current output (0.6±0.02 versus 0.56±0.02 Amp; P<0.0001) and greater impedance drop (16.8±3.0 Ω, P<0.001). Repeat ablation at similar locations had a successful effect in 12 out of 16 (75.0%) patients. During a follow-up duration of 13±5 months, 10 out of 12 (83.3%) patients remained free of arrhythmia recurrence. The frequency of steam pops was similar between the higher and lower baseline impedance settings (7.1 versus 8.2%; P=0.74). Conclusions In patients with deep ventricular substrate, reducing the baseline impedance is a simple, safe, and effective technique for increasing the effect of radiofrequency ablation. However, its combination with low-ionic solutions may increase the risk for steam pops and neurological events.

Identifiants

pubmed: 31113232
doi: 10.1161/CIRCEP.119.007336
pmc: PMC6540818
mid: NIHMS1527000
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e007336

Subventions

Organisme : NHLBI NIH HHS
ID : T32 HL007374
Pays : United States

Références

Circ Arrhythm Electrophysiol. 2010 Feb;3(1):63-71
pubmed: 20008307
Heart Rhythm. 2019 Jun;16(6):863-870
pubmed: 30576879
Circ Arrhythm Electrophysiol. 2016 Sep;9(9):
pubmed: 27625170
Circ Arrhythm Electrophysiol. 2010 Dec;3(6):616-23
pubmed: 20855374
Pacing Clin Electrophysiol. 2018 Apr;41(4):342-344
pubmed: 29430667
Am J Cardiol. 1996 Apr 1;77(9):765-7
pubmed: 8651132
Heart Rhythm. 2012 Dec;9(12):1932-41
pubmed: 22863684
J Cardiovasc Electrophysiol. 2016 Mar;27(3):351-7
pubmed: 26648095
J Cardiovasc Electrophysiol. 2013 Oct;24(10):1189-97
pubmed: 24015911
J Cardiovasc Electrophysiol. 2014 Jun;25(6):602-8
pubmed: 24576211
Circ Arrhythm Electrophysiol. 2015 Apr;8(2):337-43
pubmed: 25637596
Heart Rhythm. 2008 Oct;5(10):1411-6
pubmed: 18929327
Heart Rhythm. 2017 Jan;14(1):141-148
pubmed: 27664373
Heart Rhythm. 2007 Nov;4(11):1403-10
pubmed: 17954399
Circ Arrhythm Electrophysiol. 2018 Oct;11(10):e006690
pubmed: 30354405
Pacing Clin Electrophysiol. 2004 May;27(5):594-9
pubmed: 15125714
J Cardiovasc Electrophysiol. 1996 Jun;7(6):531-6
pubmed: 8743758
Circulation. 2017 Feb 28;135(9):867-877
pubmed: 28119381
Heart Rhythm. 2014 Jun;11(6):1031-9
pubmed: 24607720
Int J Hyperthermia. 2003 May-Jun;19(3):267-94
pubmed: 12745972
Circ Arrhythm Electrophysiol. 2011 Feb;4(1):49-55
pubmed: 21131557
JACC Clin Electrophysiol. 2018 Sep;4(9):1176-1185
pubmed: 30236391

Auteurs

Ayelet Shapira-Daniels (A)

Cardiovascular Division, Department of Medicine, Harvard-Thorndike Electrophysiology Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

Michael Barkagan (M)

Cardiovascular Division, Department of Medicine, Harvard-Thorndike Electrophysiology Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

Markus Rottmann (M)

Cardiovascular Division, Department of Medicine, Harvard-Thorndike Electrophysiology Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

Jakub Sroubek (J)

Cardiovascular Division, Department of Medicine, Harvard-Thorndike Electrophysiology Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

Derin Tugal (D)

Cardiovascular Division, Department of Medicine, Harvard-Thorndike Electrophysiology Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

Michael A Carlozzi (MA)

Cardiovascular Division, Department of Medicine, Harvard-Thorndike Electrophysiology Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

James W McConville (JW)

Cardiovascular Division, Department of Medicine, Harvard-Thorndike Electrophysiology Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

Alfred E Buxton (AE)

Cardiovascular Division, Department of Medicine, Harvard-Thorndike Electrophysiology Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

Elad Anter (E)

Cardiovascular Division, Department of Medicine, Harvard-Thorndike Electrophysiology Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH